SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-19-026190
Filing Date
2019-12-16
Accepted
2019-12-16 06:04:00
Documents
5
Period of Report
2019-12-16

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k121019_chinasxtpharma.htm 6-K 35152
2 FORM OF FORBEARANCE AGREEMENT, DATED DECEMBER [13], 2019, BY AND BETWEEN CHINA S f6k121019ex10-1_chinasxt.htm EX-10.1 67981
3 FORM OF LOCK-UP AGREEMENT, DATED DECEMBER [13], 2019, BY AND BETWEEN CHINA SXT P f6k121019ex10-2_chinasxt.htm EX-10.2 22861
4 FORM OF LEAK-OUT DATED DECEMBER [13], 2019, BY AND AMONG MR. FENG ZHOU, MR. JIAN f6k121019ex10-3_chinasxt.htm EX-10.3 17540
5 FORM OF MUTUAL RELEASE, DATED DECEMBER [13], 2019, BY AND BETWEEN CHINA SXT PHAR f6k121019ex10-4_chinasxt.htm EX-10.4 16686
  Complete submission text file 0001213900-19-026190.txt   161206
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300
Business Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300 8652386298290
China SXT Pharmaceuticals, Inc. (Filer) CIK: 0001723980 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-38773 | Film No.: 191285767
SIC: 2834 Pharmaceutical Preparations